Structure of MurA (UDP-<i>N</i>-acetylglucosamine enolpyruvyl transferase) from<i>Vibrio fischeri</i>in complex with substrate UDP-<i>N</i>-acetylglucosamine and the drug fosfomycin
Daniel C. Bensen(State Street (United States)), L.W. Tari(Arcturus Therapeutics (United States)), Jay C. Nix(Lawrence Berkeley National Laboratory), Sergio E. Rodriguez(Arcturus Therapeutics (United States)), M. L. Cunningham(Arcturus Therapeutics (United States))
Acta Crystallographica Section F Structural Biology and Crystallization Communications
March 26, 2012
Cited by 22
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Comparative Genomic Analysis of Archaeal Genotypic Variants in a Single Population and in Two Different Oceanic Provinces
|Applied and Environmental Microbiology|2002|171
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE). Part I: Structure guided discovery and optimization of dual targeting agents with potent, broad-spectrum enzymatic activity
|Bioorganic & Medicinal Chemistry Letters|2012|118
Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents
|PLoS ONE|2013|104
Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: Development of inhibitors with broad spectrum, Gram-negative antibacterial activity
|Bioorganic & Medicinal Chemistry Letters|2012|81